Immune cell repertoires in breast cancer patients after adjuvant chemotherapy.
Ontology highlight
ABSTRACT: Adjuvant chemotherapy in breast cancer patients causes immune cell depletion at an age when the regenerative capacity is compromised. Successful regeneration requires the recovery of both quantity and quality of immune cell subsets. Although immune cell numbers rebound within a year after treatment, it is unclear whether overall compositional diversity is recovered. We investigated the regeneration of immune cell complexity by comparing peripheral blood mononuclear cells from breast cancer patients ranging from 1-5 years after chemotherapy with those of age-matched healthy controls using mass cytometry and T cell receptor sequencing. These data reveal universal changes in patients' CD4+ T cells that persisted for years and consisted of expansion of Th17-like CD4 memory populations with inc
SUBMITTER: Gustafson CE
PROVIDER: S-EPMC7101137 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA